Insider Transactions
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 26, 2019 |
Director, Chairman, Pres. & CEO
|
Director, Chairman, Pres. & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 24,139 | $307.07 | 84,492 |
| Jan 27, 2014 |
Director, Chairman, Pres. & CEO
|
Director, Chairman, Pres. & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 24,544 | $147.75 | -- |
| Jul 19, 2017 |
Director, Chairman, Pres. & CEO
|
Director, Chairman, Pres. & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 26,000 | $290.53 | 83,978 |
| Jan 29, 2018 |
Director, Chairman, Pres. & CEO
|
Director, Chairman, Pres. & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 28,162 | $351.42 | 111,740 |
| Jul 28, 2014 |
Director, Chairman, Pres. & CEO
|
Director, Chairman, Pres. & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 29,600 | $82.52 | 34,657 |
| Jul 28, 2014 |
Director, Chairman, Pres. & CEO
|
Director, Chairman, Pres. & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 29,600 | -- | -- |
| Feb 22, 2021 |
Director, Executive Chairman
|
Director, Executive Chairman | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 31,792 | -- | 71,705 |
| Jan 28, 2016 |
Director, Chairman, Pres. & CEO
|
Director, Chairman, Pres. & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 34,289 | -- | 173,557 |
| Jan 28, 2016 |
Director, Chairman, Pres. & CEO
|
Director, Chairman, Pres. & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 34,289 | -- | -- |
| Jan 28, 2013 |
Director, CEO and President
|
Director, CEO and President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 34,289 | -- | 34,289 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.